Literature DB >> 2417905

Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content.

E G Siegel, W Creutzfeldt.   

Abstract

Several insulinotropic hormones have been shown to increase the level of cyclic AMP in isolated islets. This study was performed to investigate whether gastric inhibitory polypeptide (glucose-dependent insulin-releasing polypeptide) has a similar effect, in particular at concentrations close to the physiological level in blood. Collagenase isolated rat islets were maintained for 24 h in tissue culture (medium 199) and then incubated for 30 min for measurement of insulin release and cyclic AMP content. Glucose-induced (16.7 mmol/l) insulin release was enhanced by gastric inhibitory polypeptide 1-100 ng/ml (0.196-19.6 nmol/l) in a dose-related fashion. The cyclic AMP content was enhanced only by 100 ng/ml. However, when 0.1 mmol/l of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine was present, even 1 ng/ml of gastric inhibitory polypeptide increased both cyclic AMP content and insulin release. Such a concentration of the hormone can be measured in human blood after a meal. In contrast, in freshly isolated islets no effect of the hormone on glucose-induced insulin release or cyclic AMP content could be detected for concentrations ranging from 1 to 100 ng/ml. These findings demonstrate that the hormone sensitivity of isolated islets is markedly enhanced by short-term maintenance in tissue culture. The results suggest that an increase in cyclic AMP is seen in response to gastric inhibitory polypeptide and may be causally related to the insulinotropic effect of the hormone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417905     DOI: 10.1007/bf00291078

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

Review 2.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.

Authors:  D Elahi; D K Andersen; J C Brown; H T Debas; R J Hershcopf; G S Raizes; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-08

4.  Adenosine 3',5' cyclic monophosphate assay at 10-15 mole level.

Authors:  H L Cailla; M S Racine-Weisbuch; M A Delaage
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat.

Authors:  J Szecówka; V Grill; E Sandberg; S Efendić
Journal:  Acta Endocrinol (Copenh)       Date:  1982-03

7.  Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas.

Authors:  R Schäfer; H Schatz
Journal:  Acta Endocrinol (Copenh)       Date:  1979-07

8.  Dependency of cyclic AMP-induced insulin release on intra- and extracellular calcium in rat islets of Langerhans.

Authors:  E G Siegel; C B Wollheim; M Kikuchi; A E Renold; G W Sharp
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

9.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

10.  Effects of gastric inhibitory polypeptide on leucine- and arginine-stimulated insulin release.

Authors:  E L Mazzaferri; L Ciofalo; L A Waters; G H Starich; J C Groshong; L DePalma
Journal:  Am J Physiol       Date:  1983-08
View more
  13 in total

Review 1.  [Normoglycemia as a therapy goal in diabetes treatment--concept and realization].

Authors:  E G Siegel
Journal:  Klin Wochenschr       Date:  1990-03-16

2.  Homogeneous Assays of Second Messenger Signaling and Hormone Secretion Using Thermofluorimetric Methods That Minimize Calibration Burden.

Authors:  Juan Hu; Christopher J Easley
Journal:  Anal Chem       Date:  2017-07-25       Impact factor: 6.986

Review 3.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

4.  Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.

Authors:  E J Verspohl; G Wunderle; H P Ammon; J A Williams; I D Goldfine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

Review 5.  GIP and bariatric surgery.

Authors:  Raghavendra S Rao; Subhash Kini
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

6.  Noncanonical activation of Akt/protein kinase B in {beta}-cells by the incretin hormone glucose-dependent insulinotropic polypeptide.

Authors:  Scott B Widenmaier; Arthur V Sampaio; T Michael Underhill; Christopher H S McIntosh
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

7.  Insulin secretion by rat islet isografts of a defined endocrine volume after transplantation to three different sites.

Authors:  P T van Suylichem; J H Strubbe; H Houwing; G H Wolters; R van Schilfgaarde
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

8.  Cholecystokinin (CCK8) regulates glucagon, insulin, and somatostatin secretion from isolated rat pancreatic islets: interaction with glucose.

Authors:  E J Verspohl; H P Ammon
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

9.  Stomachs: does the size matter? Aspects of intestinal satiety, gastric satiety, hunger and gluttony.

Authors:  Sergio Santoro
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.

Authors:  Ghupurjan Gheni; Masahito Ogura; Masahiro Iwasaki; Norihide Yokoi; Kohtaro Minami; Yasumune Nakayama; Kazuo Harada; Benoit Hastoy; Xichen Wu; Harumi Takahashi; Kazushi Kimura; Toshiya Matsubara; Ritsuko Hoshikawa; Naoya Hatano; Kenji Sugawara; Tadao Shibasaki; Nobuya Inagaki; Takeshi Bamba; Akira Mizoguchi; Eiichiro Fukusaki; Patrik Rorsman; Susumu Seino
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.